[Antigenicity study of cefpirome sulfate]

Area of Science:

• Pharmacology and Immunology
• Antibiotic Safety Evaluation

Background:

• Assessing the immunological properties of novel antibiotics is crucial for ensuring patient safety.
• Cefpirome sulfate (CPR) is a cephalosporin antibiotic requiring thorough immunogenicity testing.

Purpose of the Study:

• To evaluate the immunogenicity and cross-reactivity of cefpirome sulfate (CPR).
• To assess the challenging ability and in vitro immunological reactions of CPR.

Main Methods:

• Active systemic anaphylaxis (ASA) and passive cutaneous anaphylaxis (PCA) tests in guinea pigs.
• Heterologous PCA, passive hemagglutination, and direct Coombs tests were employed.
• Sensitization involved antibiotics with and without Freund's complete adjuvant (FCA).

Main Results:

• CPR alone did not induce ASA or PCA reactions; however, with FCA, ASA and PCA were observed.
• CPR demonstrated challenging ability in ASA and PCA reactions, with cross-reactivity noted against cefotaxime sodium (CTX).
• Direct Coombs tests showed varying positive reactions for CPR compared to other beta-lactam antibiotics.

Conclusions:

• Cefpirome sulfate (CPR) exhibits low intrinsic immunogenicity.
• Despite some cross-reactivity, the antigenic potential of CPR is unlikely to pose a significant safety concern.
• Findings support the safety profile of CPR in the context of immunological properties.